• Home
  • Attendees
  • Program + Events
  • Presenters
  • Exhibitors
  • Press & Media
  • Meeting Updates
  • Official List of Lysosomal Diseases
  • Resources
  • Contact
  • Search
  • Get Updates
  • About
  • Official List of Lysosomal Diseases
  • Resources
  • Contact
Logo
  • Home
    • About
  • Attendees
    • Registration
    • WORLDSymposium 2021 Virtual Platform
    • WORLDSymposium 2021 Mobile App
    • Continuing Education
    • Hotel Reservations
    • Travel Information
    • Attendee, Registration & Hotel FAQs
    • General Information
    • Documents & Downloads
  • Program + Events
    • Program
    • Keynote Speakers
    • Poster Sessions
    • Emerging Trends 2021
    • Satellite Symposia
    • Scholarships and Awards
    • Lysosomal Disease Network Meeting
    • Social Media Guidelines
    • Future Meeting Dates
    • Previous Meetings
  • Presenters
    • Abstract Submissions
    • Late-Breaking Abstracts
    • Rules & Policies
    • Platform Speaker Presentation Guidelines
    • Contemporary Forum Speaker Presentation Guidelines
    • Keywords
    • Abstract Submissions & Publication FAQs
    • Platform Speaker FAQs
    • Poster Presenter FAQs
    • Abstract Assignments & Poster List
  • Exhibitors
    • Why Exhibit & Prospectus
    • Past Exhibiting Companies
  • Press
  • Menu
WORLDSymposium
  • HOME
  • Attendees
  • Documents & Downloads

Documents & Downloads

Files will be added as they become available.

WORLDSymposium 2020 Program

WORLDSymposium 2020 Poster List

Attendee Information

  • Registration
  • WORLDSymposium 2021 Virtual Platform
  • WORLDSymposium 2021 Mobile App
  • Continuing Education
  • Attendee, Registration & Hotel FAQs
  • General Information
  • Documents & Downloads

Contact Information

  • WORLDSymposia c/o GMI
    6001 Broken Sound Pkwy NW – Suite 340
    Boca Raton, FL 33487
  • E-mail: info@nullworldsymposia.org
  • Get updates about WORLDSymposium

WORLDSymposium™ is an annual research conference dedicated to lysosomal diseases.

WORLD is an acronym that stands for We’re Organizing Research on Lysosomal Diseases.

Each year, WORLDSymposium presents the latest information from basic science, translational research, and clinical trials for lysosomal diseases.

Recent Tweets

12 Feb

Elizabeth M. Berry-Kravis presents Evidence for long-term efficacy of intrathecal adrabetadex for the treatment of neurological decline in patients with Niemann-Pick disease, type C1 #WORLDSymposia

Reply on Twitter 1360296897156685824Retweet on Twitter 13602968971566858241Like on Twitter 13602968971566858244
12 Feb

Anna I. Bakardjiev presents Intravenous ETV:IDS (DNL310) significantly reduces cerebrospinal fluid heparan sulfate in an open label Ph1/2 study in MPS II patients #WORLDSymposia

Reply on Twitter 1360293905636466688Retweet on Twitter 13602939056364666881Like on Twitter 13602939056364666881
12 Feb

Maria J. de Castro presents Updated results of Transpher B, a multicenter, single-dose, phase 1/2 clinical trial of ABO-101 gene therapy for Sanfilippo syndrome type B (MPS IIIB) #WORLDSymposia

Reply on Twitter 1360290822672023553Retweet on Twitter 13602908226720235531Like on Twitter 13602908226720235534

Plan to attend the

18th Annual WORLDSymposium
February 7 – 10, 2022
Manchester Grand Hyatt, San Diego, CA, USA

© Copyright 2021 WORLDSymposium. All Rights Reserved.   |   Privacy Policy

WORLDSymposium is a medical education conference focused on lysosomal diseases, which is wholly owned and operated by WORLDSymposia, Ltd. WORLDSymposium is independently managed by GMI, Inc. and Saterdalen & Associates, LLC. GMI and Saterdalen & Associates are independent entities, and are not partners, co-venturers or agents of WORLDSymposia, Ltd.

WORLDSymposium and the Lysosomal Disease Network (LDN) are separate and independent entities and are not affiliated in any way. WORLDSymposium receives NO FUNDING of any kind from the LDN, the National Institutes of Health (NIH), or any other federal agency.

The Lysosomal Disease Network (U54NS065768) is a part of the National Institutes of Health (NIH) Rare Diseases Clinical Research Network (RDCRN), supported through collaboration between the NIH Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Science (NCATS), the National Institute of Neurological Disorders and Stroke (NINDS) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).